Aeglea BioTherapeutics, Inc. Contracts & Agreements

157 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Underwriting Agreement, by and among the Company and
Underwriting Agreements
Aeglea BioTherapeutics, Inc.
2024
Fifth Amendment to the Spyre Therapeutics, Inc. 2018 Equity Inducement Plan
Aeglea BioTherapeutics, Inc.
2024
Offer Letter, dated September 20, 2024, by and between the Company and Sheldon Sloan
Aeglea BioTherapeutics, Inc.
2024
IL-23 (SPY003) License Agreement, dated October 11, 2024, by and between the Company and Paragon Therapeutics, Inc
License Agreements
Aeglea BioTherapeutics, Inc.
2024
Amended and Restated Biologics Master Services Agreement, dated October 14, 2024, by and between the Company and WuXi Biologics (Hong Kong) Limited
Services Agreements
Aeglea BioTherapeutics, Inc.
2024
Amended and Restated Cell Line License Agreement, dated October 14, 2024, by and between the Company and WuXi Biologics (Hong Kong) Limited
License Agreements
Aeglea BioTherapeutics, Inc.
2024
47 (SPY001) License Agreement, dated May 14, 2024, by and between the Company and Paragon Therapeutics, Inc
License Agreements
Aeglea BioTherapeutics, Inc.
2024
TL1A (SPY002) License Agreement, dated May 14 2024, by and between the Company and Paragon Therapeutics, Inc
License Agreements
Aeglea BioTherapeutics, Inc.
2024
Second Amended and Restated Antibody Discovery and Option Agreement, dated May 14, 2024, by and between the Company, Paragon Therapeutics, Inc. and Parapyre Holding LLC
Aeglea BioTherapeutics, Inc.
2024
Form of Stock Option Agreement under the Amended and Restated Spyre Therapeutics, Inc. 2016 Equity Incentive Plan
Bonus & Incentive Agreements
Aeglea BioTherapeutics, Inc.
2024
Form of Restricted Stock Unit Award Agreement under the Amended Spyre Therapeutics, Inc. 2018 Equity Inducement Plan
Stock Agreements
Aeglea BioTherapeutics, Inc.
2024
Form of Warrant to Purchase Common Stock (Parapyre Warrant 2023)
Warrant Agreements
Aeglea BioTherapeutics, Inc.
2024
Amendment No. 1 to
Aeglea BioTherapeutics, Inc.
2024
Exchange Agreement, dated April 23, 2024, by and between the Company and Fairmount Healthcare Fund II L.P
Exchange Agreements
Aeglea BioTherapeutics, Inc.
2024
Securities Purchase Agreement, dated as of March 18, 2024, by and among Spyre Therapeutics, Inc. and each purchaser identified on Annex A thereto
Purchase Agreements
Aeglea BioTherapeutics, Inc.
2024
Form of Registration Rights Agreement
Registration Rights Agreements
Aeglea BioTherapeutics, Inc.
2024
Spyre Therapeutics, Inc. 2016 Employee Stock Purchase Plan, as amended by the First Amendment on January 31, 2024
Stock Agreements
Aeglea BioTherapeutics, Inc.
2024
Offer Letter, dated August 18, 2023, by and between the Company and Heidy King-Jones
Aeglea BioTherapeutics, Inc.
2024
Consulting Agreement by and between the Company and Mark McKenna, effective August 1, 2023
Consulting Agreements
Aeglea BioTherapeutics, Inc.
2024
Description of the Registrant's securities
Aeglea BioTherapeutics, Inc.
2024
Spyre Therapeutics, Inc
Aeglea BioTherapeutics, Inc.
2024
Offer Letter, dated August 1
Aeglea BioTherapeutics, Inc.
2024
Consulting Agreement by and between the Company and Mark McKenna, effective August 1, 2023
Consulting Agreements
Aeglea BioTherapeutics, Inc.
2024
Form of Indemnification Agreement
Indemnification Agreements
Aeglea BioTherapeutics, Inc.
2024
Amendment to the Amended and Restated Letter Agreement by and between the Company and Cameron Turtle, dated as of February 1, 2024
Aeglea BioTherapeutics, Inc.
2024
Amended and Restated Offer Letter, dated November 22, 2023 and as amended on February 1, 2024, by and between the Company and Cameron Turtle
Aeglea BioTherapeutics, Inc.
2024
2024 Form of Indemnification Agreement
Indemnification Agreements
Aeglea BioTherapeutics, Inc.
2024
Agreement and Plan of Merger, dated June 22, 2023, by and among the Company, Aspen Merger Sub I, Inc., Sequoia Merger Sub II, LLC and Spyre Therapeutics, Inc
Merger Agreements
Aeglea BioTherapeutics, Inc.
2023
Form of Registration Rights Agreement (December 2023 PIPE)
Registration Rights Agreements
Aeglea BioTherapeutics, Inc.
2023
Form of Common Stock Certificate
Stock Agreements
Aeglea BioTherapeutics, Inc.
2023
Securities Purchase Agreement, dated December 7, 2023, by and among Spyre Therapeutics, Inc. and each purchaser identified on Annex A thereto
Purchase Agreements
Aeglea BioTherapeutics, Inc.
2023
Form of Registration Rights Agreement, by and among the Company and certain purchasers (June 2023 PIPE)
Registration Rights Agreements
Aeglea BioTherapeutics, Inc.
2023
Form of Pre-Funded Warrants 2022
Aeglea BioTherapeutics, Inc.
2023
Biologics Master Services Agreement, effective June 20, 2022, by and between Paragon Therapeutics, Inc. and WuXi Biologics (Hong Kong) Limited
Services Agreements
Aeglea BioTherapeutics, Inc.
2023
Cell Line License Agreement, effective June 20, 2022, by and between Paragon Therapeutics, Inc. and WuXi Biologics (Hong Kong) Limited
License Agreements
Aeglea BioTherapeutics, Inc.
2023
Novation Agreement, dated September 19, 2023, by and between Paragon Therapeutics, Inc., the Company and WuXi Biologics (Hong Kong) Limited
Aeglea BioTherapeutics, Inc.
2023
Amended and Restated Offer Letter, dated November 22, 2023, by and between the Company and Cameron Turtle
Aeglea BioTherapeutics, Inc.
2023
Amended and Restated Antibody Discovery and Option agreement, dated September 29, 2023, by and between Paragon Therapeutics, Inc., Parapyre Holding LLC and Spyre Therapeutics, LLC
Aeglea BioTherapeutics, Inc.
2023
Form of Amended and Restated Indemnification Agreement
Indemnification Agreements
Aeglea BioTherapeutics, Inc.
2023
2015 Equity Incentive Plan and forms of award agreements
Bonus & Incentive Agreements
Aeglea BioTherapeutics, Inc.
2023
Spyre Therapeutics, Inc. 2016 Equity Incentive Plan, As Amended and Restated Effective November 21, 2023
Bonus & Incentive Agreements
Aeglea BioTherapeutics, Inc.
2023
2016 Employee Stock Purchase Plan and forms of award agreements, as amended
Stock Agreements
Aeglea BioTherapeutics, Inc.
2023
Spyre Therapeutics, Inc. 2018 Equity Inducement Plan and the First Amendment, Second Amendment, Third Amendment and Fourth Amendment thereto
Aeglea BioTherapeutics, Inc.
2023
Form of Stock Option Agreement under the Amended and Restated 2018 Equity Inducement Plan
Stock Agreements
Aeglea BioTherapeutics, Inc.
2023
Spyre Therapeutics, Inc. 2023 Equity Incentive Plan
Bonus & Incentive Agreements
Aeglea BioTherapeutics, Inc.
2023
Form of Stock Restriction Agreement
Stock Agreements
Aeglea BioTherapeutics, Inc.
2023
Form of Severance Agreement
Severance Agreements
Aeglea BioTherapeutics, Inc.
2023
Separation and Consulting Agreement and General Release of Claims by and between the Company and Jonathan Alspaugh, dated as of September 22, 2023
Consulting Agreements
Aeglea BioTherapeutics, Inc.
2023
Offer Letter, dated August 10, 2023, by and between the Company and Scott Burrows
Aeglea BioTherapeutics, Inc.
2023
Asset Purchase Agreement, dated July 27, 2023, by and between the Company and Immedica Pharma AB
Purchase Agreements
Aeglea BioTherapeutics, Inc.
2023
Lease Termination Agreement dated August 7, 2023, between the Company and Las Cimas Owner LP
Lease Agreements
Aeglea BioTherapeutics, Inc.
2023
Securities Purchase Agreement, dated as of December 7, 2023, by and among Spyre Therapeutics, Inc. and each purchaser identified on Annex A thereto
Purchase Agreements
Aeglea BioTherapeutics, Inc.
2023
Form of Registration Rights Agreement
Registration Rights Agreements
Aeglea BioTherapeutics, Inc.
2023
Amended and restated letter agreement by and between the Company and Cameron Turtle, dated as of November 22, 2023
Aeglea BioTherapeutics, Inc.
2023
Agreement and Plan of Merger, dated June 22, 2023, by and among Aeglea BioTherapeutics, Inc. Aspen Merger Sub I, Inc., Sequoia Merger Sub II, LLC and Spyre Therapeutics, Inc
Merger Agreements
Aeglea BioTherapeutics, Inc.
2023
Securities Purchase Agreement, dated June 22, 2023, by and among the Registrant and the purchasers named therein
Purchase Agreements
Aeglea BioTherapeutics, Inc.
2023
Form of Common Stock Certificate
Stock Agreements
Aeglea BioTherapeutics, Inc.
2023
Registration Rights Agreement, dated March 16, 2021, by and among the Registrant and Baker Brothers Life Sciences, L.P. and 667, L.P
Registration Rights Agreements
Aeglea BioTherapeutics, Inc.
2023
Form of Registration Rights Agreement, by and among Aeglea BioTherapeutics, Inc. and certain purchasers
Registration Rights Agreements
Aeglea BioTherapeutics, Inc.
2023
Form of Pre-Funded Warrants 2022
Aeglea BioTherapeutics, Inc.
2023
Offer Letter, dated June 22, 2023, by and between Aeglea BioTherapeutics, Inc. and Cameron Turtle
Aeglea BioTherapeutics, Inc.
2023
Form of Amended and Restated Indemnification Agreement
Indemnification Agreements
Aeglea BioTherapeutics, Inc.
2023
2015 Equity Incentive Plan and forms of award agreements
Bonus & Incentive Agreements
Aeglea BioTherapeutics, Inc.
2023
2016 Equity Incentive Plan and forms of award agreements, as amended
Bonus & Incentive Agreements
Aeglea BioTherapeutics, Inc.
2023
First Amendment to the Aeglea BioTherapeutics, Inc. 2016 Equity Incentive Plan
Bonus & Incentive Agreements
Aeglea BioTherapeutics, Inc.
2023
2016 Employee Stock Purchase Plan and forms of award agreements, as amended
Stock Agreements
Aeglea BioTherapeutics, Inc.
2023
2018 Equity Inducement Plan
Aeglea BioTherapeutics, Inc.
2023
First Amendment to the Aeglea BioTherapeutics, Inc. 2018 Equity Inducement Plan
Aeglea BioTherapeutics, Inc.
2023
Third Amendment to the Aeglea BioTherapeutics, Inc. 2018 Equity Inducement Plan
Aeglea BioTherapeutics, Inc.
2023
Form of Stock Option Agreement under the Aeglea BioTherapeutics, Inc. 2018 Equity Inducement Plan
Stock Agreements
Aeglea BioTherapeutics, Inc.
2023
Amended and Restated Spyre 2023 Equity Incentive Plan
Bonus & Incentive Agreements
Aeglea BioTherapeutics, Inc.
2023
Form of Stock Restriction Agreement
Stock Agreements
Aeglea BioTherapeutics, Inc.
2023
Form of Severance Agreement
Severance Agreements
Aeglea BioTherapeutics, Inc.
2023
Separation and Consulting Agreement and General Release of Claims by and between the Company and Jonathan Alspaugh, dated as of September 22, 2023
Consulting Agreements
Aeglea BioTherapeutics, Inc.
2023
Offer Letter, dated August 10, 2023, by and between the Company and Scott Burrows
Aeglea BioTherapeutics, Inc.
2023
Asset Purchase Agreement, dated July 27, 2023, by and between Aeglea BioTherapeutics, Inc. and Immedica Pharma AB
Purchase Agreements
Aeglea BioTherapeutics, Inc.
2023
Biologics Master Services Agreement, effective June 20, 2022, by and between Paragon Therapeutics, Inc. and WuXi Biologics (Hong Kong) Limited
Services Agreements
Aeglea BioTherapeutics, Inc.
2023
Cell Line License Agreement, effective June 20, 2022, by and between Paragon Therapeutics, Inc. and WuXi Biologics (Hong Kong) Limited
License Agreements
Aeglea BioTherapeutics, Inc.
2023
Novation Agreement, dated September 19, 2023, by and between Paragon Therapeutics, Inc., Aeglea BioTherapeutics, Inc. and WuXi Biologics (Hong Kong) Limited
Aeglea BioTherapeutics, Inc.
2023
Amended and Restated Antibody Discovery and Option agreement, dated September 29, 2023, by and between Paragon Therapeutics, Inc., Parapyre Holding LLC and Spyre Therapeutics, LLC
Aeglea BioTherapeutics, Inc.
2023
Second Amendment to the Aeglea BioTherapeutics, Inc. 2018 Equity Inducement Plan
Aeglea BioTherapeutics, Inc.
2023
Lease Termination Agreement dated August 7, 2023, between Aeglea BioTherapeutics, Inc. and Las Cimas Owner LP
Lease Agreements
Aeglea BioTherapeutics, Inc.
2023
Separation and Consulting Agreement and General Release of Claims by and between the Company and Jonathan Alspaugh, dated as of September 22, 2023
Consulting Agreements
Aeglea BioTherapeutics, Inc.
2023
Offer Letter by and between the Company and Scott Burrows, dated as of August 10, 2023
Aeglea BioTherapeutics, Inc.
2023
Offer Letter, dated June 22, 2023, by and between Aeglea BioTherapeutics, Inc. and Cameron Turtle
Aeglea BioTherapeutics, Inc.
2023
Antibody Discovery and Option agreement, dated May 25, 2023, by and between Paragon Therapeutics, Inc., Parapyre Holding LLC and Spyre Therapeutics, Inc
Aeglea BioTherapeutics, Inc.
2023
First Amendment to the Aeglea BioTherapeutics, Inc. 2016 Equity Incentive Plan
Bonus & Incentive Agreements
Aeglea BioTherapeutics, Inc.
2023
First Amendment to the Aeglea BioTherapeutics, Inc. 2018 Equity Inducement Plan
Aeglea BioTherapeutics, Inc.
2023
Amended and Restated Spyre 2023 Equity Incentive Plan
Bonus & Incentive Agreements
Aeglea BioTherapeutics, Inc.
2023
Form of Stock Option Agreement under the Aeglea BioTherapeutics, Inc. 2018 Equity Inducement Plan
Stock Agreements
Aeglea BioTherapeutics, Inc.
2023
Asset Purchase Agreement, dated July 27, 2023, by and between Aeglea BioTherapeutics, Inc. and Immedica Pharma AB
Purchase Agreements
Aeglea BioTherapeutics, Inc.
2023
Agreement and Plan of Merger, dated June 22, 2023, by and among Aeglea BioTherapeutics, Inc. Aspen Merger Sub I, Inc., Sequoia Merger Sub II, LLC and Spyre Therapeutics, Inc
Merger Agreements
Aeglea BioTherapeutics, Inc.
2023
Securities Purchase Agreement, dated as of June 22, 2023, by and among Aeglea BioTherapeutics, Inc. and each purchaser identified on Annex A thereto
Purchase Agreements
Aeglea BioTherapeutics, Inc.
2023
Form of Registration Rights Agreement, by and among Aeglea BioTherapeutics, Inc. and certain purchasers
Registration Rights Agreements
Aeglea BioTherapeutics, Inc.
2023
Capital on DemandTM Sales Agreement, dated May 20, 2022, by and between Aeglea BioTherapeutics, Inc. and JonesTrading Institutional Services LLC
Sales Agreements
Aeglea BioTherapeutics, Inc.
2022
Form of Pre-Funded Warrant
Warrant Agreements
Aeglea BioTherapeutics, Inc.
Biotechnology
NY
2022
Form of Securities Purchase Agreement, dated as of May 5, 2022, by and among Aeglea BioTherapeutics, Inc. and the purchasers identified therein
Purchase Agreements
Aeglea BioTherapeutics, Inc.
Biotechnology
NY
2022
Offer Letter, dated June 14, 2021 issued by the Registrant to Mr. Jonathan Alspaugh
Aeglea BioTherapeutics, Inc.
2022
Severance Agreement dated July 6, 2021 by and between the Registrant and Mr. Jonathan Alspaugh
Severance Agreements
Aeglea BioTherapeutics, Inc.
2022
License and Supply Agreement, dated March 21, 2021, by and between the Registrant and Immedica Pharma AB
License Agreements
Aeglea BioTherapeutics, Inc.
2021
Description of the Registrant's securities
Aeglea BioTherapeutics, Inc.
2021
Registration Rights Agreement, dated March 16, 2021, by and among the Registrant and Baker Brothers Life Sciences, L.P. and 667, L.P
Registration Rights Agreements
Aeglea BioTherapeutics, Inc.
Biotechnology
NY
2021
Offer letter, dated March 13, 2020 issued by the Registrant to Dr. Leslie Sloan
Aeglea BioTherapeutics, Inc.
Biotechnology
2020
Severance Agreement dated August 7, 2019 by and between the Registrant and Dr. Leslie Sloan
Severance Agreements
Aeglea BioTherapeutics, Inc.
2020
Underwriting Agreement dated April 28, 2020
Underwriting Agreements
Aeglea BioTherapeutics, Inc.
2020
Form of Pre-Funded Warrant
Warrant Agreements
Aeglea BioTherapeutics, Inc.
Biotechnology
NY
2020
Capital on DemandTM Sales Agreement, dated April 16, 2020, by and between Aeglea BioTherapeutics, Inc. and JonesTrading Institutional Services LLC
Sales Agreements
Aeglea BioTherapeutics, Inc.
Biotechnology
NY
2020
Description of the Registrant's securities
Aeglea BioTherapeutics, Inc.
Biotechnology
2020
Lease Agreement, dated April 30, 2019, between Las Cimas Owner LP and the Registrant
Lease Agreements
Aeglea BioTherapeutics, Inc.
2019
Amendment #1, dated December 4, 2018, to Amendment and Restated Investors' Rights Agreement, as amended
Investor Rights Agreements
Aeglea BioTherapeutics, Inc.
2019
2016 Employee Stock Purchase Plan and forms of award agreements, as amended
Stock Agreements
Aeglea BioTherapeutics, Inc.
Biotechnology
DE
2019
Amended and Restated Patent License Agreement No. PM1401501, dated January 31, 2017, between the Registrant and The University of Texas at Austin on behalf of the Board of Regents...
License Agreements
Aeglea BioTherapeutics, Inc.
Biotechnology
TX
2019
Master Services Agreement, dated November 26, 2018, between the Registrant, Fujifilm Diosynth Biotechnologies UK Limited, Fujifilm Diosynth Biotechnologies Texas, LLC, and...
Services Agreements
Aeglea BioTherapeutics, Inc.
2019
Underwriting Agreement dated February 5, 2019, as amended
Underwriting Agreements
Aeglea BioTherapeutics, Inc.
Biotechnology
NY
2019
Form of Pre-Funded Warrant
Warrant Agreements
Aeglea BioTherapeutics, Inc.
2019
Amended and Restated 2016 Equity Incentive Plan
Bonus & Incentive Agreements
Aeglea BioTherapeutics, Inc.
2018
Form of Amended and Restated Indemnification Agreement
Indemnification Agreements
Aeglea BioTherapeutics, Inc.
Biotechnology
DE
2018
Offer Letter, dated July 18, 2018 by and between the Company and Anthony G. Quinn
Aeglea BioTherapeutics, Inc.
2018
Severance Agreement, dated July 18, 2018 by and between the Company and Anthony G. Quinn
Severance Agreements
Aeglea BioTherapeutics, Inc.
2018
Underwriting Agreement dated April 18, 2018
Underwriting Agreements
Aeglea BioTherapeutics, Inc.
Biotechnology
NY
2018
Form of Severance Agreement
Severance Agreements
Aeglea BioTherapeutics, Inc.
2018
Amended and Restated Patent License Agreement No. PM1401501, dated January 31, 2017, between the Registrant and The University of Texas at Austin on behalf of the Board of Regents...
License Agreements
Aeglea BioTherapeutics, Inc.
2018
Offer Letter, dated June 20, 2017, issued by the Registrant to Dr. James Wooldridge
Aeglea BioTherapeutics, Inc.
2018
Offer Letter, dated August 31, 2017, issued by the Registrant to Dr. Anthony Quinn
Aeglea BioTherapeutics, Inc.
Biotechnology
2017
Sponsored Research Agreement No. UTA13-001113, dated December 24, 2013, between The University of Texas at Austin and Aeglea BioTherapeutics, Inc., Aeglea Development Company,...
Development Agreements
Aeglea BioTherapeutics, Inc.
Biotechnology
TX
2017
Terms of Resignation between the Registrant and Dr. David G. Lowe
Aeglea BioTherapeutics, Inc.
Biotechnology
TX
2017
UNDERWRITING AGREEMENT 3,000,000Shares AEGLEA BIOTHERAPEUTICS, INC. Common Stock ($0.0001 Par Value) EQUITY UNDERWRITING AGREEMENT
Underwriting Agreements
Aeglea BioTherapeutics, Inc.
2017
Offer Letter, dated April 21, 2017, issued by the Registrant to Dr. Anthony Quinn
Aeglea BioTherapeutics, Inc.
2017
Amended and Restated Patent License Agreement Agreement No. PM1401501
License Agreements
Aeglea BioTherapeutics, Inc.
2017
Exhibit a
Aeglea BioTherapeutics, Inc.
2017
Vice President of Finance Severance Agreement
Severance Agreements
Aeglea BioTherapeutics, Inc.
Biotechnology
TX
2017
FIRST AMENDMENT TO OFFICE LEASE AND ASSIGNMENT AND ASSUMPTION OF LEASE
Lease Agreements
Aeglea BioTherapeutics, Inc.
Biotechnology
DE
2016
SPONSORED RESEARCH AGREEMENT NO. UTA13-001113
Aeglea BioTherapeutics, Inc.
2016
[ ] Shares Aeglea BioTherapeutics, Inc. COMMON STOCK UNDERWRITING AGREEMENT
Underwriting Agreements
Aeglea BioTherapeutics, Inc.
2016
AEGLEA BIOTHERAPEUTICS, INC. 2016 EQUITY INCENTIVE PLAN
Bonus & Incentive Agreements
Aeglea BioTherapeutics, Inc.
2016
AEGLEA BIOTHERAPEUTICS, INC. 2016 EMPLOYEE STOCK PURCHASE PLAN
Stock Agreements
Aeglea BioTherapeutics, Inc.
2016
SPONSORED RESEARCH AGREEMENT NO. UTA13-001113
Aeglea BioTherapeutics, Inc.
2016
VICE PRESIDENT SEVERANCE AGREEMENT
Severance Agreements
Aeglea BioTherapeutics, Inc.
Biotechnology
TX
2016
SPONSORED RESEARCH AGREEMENT NO. UTA13-001113
Aeglea BioTherapeutics, Inc.
Biotechnology
TX
2015
Additional abbreviations may also be used though not in the above list. FOR VALUE RECEIVED, hereby sell(s), assign(s) and transfer(s) unto
Aeglea BioTherapeutics, Inc.
Biotechnology
2015
INDEMNITY AGREEMENT
Aeglea BioTherapeutics, Inc.
2015
EXECUTIVE EMPLOYMENT AGREEMENT
Employment Agreements
Aeglea BioTherapeutics, Inc.
Biotechnology
TX
2015
SPONSORED RESEARCH AGREEMENT NO. UTA13-001113
Aeglea BioTherapeutics, Inc.
2015
Master Services Agreement
Services Agreements
Aeglea BioTherapeutics, Inc.
Biotechnology
NC
2015
PATENT LICENSE AGREEMENT AGREEMENT NO. PM1401601
License Agreements
Aeglea BioTherapeutics, Inc.
Biotechnology
TX
2015
CEO SERVERANCE AGREEMENT
Aeglea BioTherapeutics, Inc.
Biotechnology
TX
2015
VICE PRESIDENT SEVERANCE AGREEMENT
Severance Agreements
Aeglea BioTherapeutics, Inc.
2015
VICE PRESIDENT SEVERANCE AGREEMENT
Severance Agreements
Aeglea BioTherapeutics, Inc.
Biotechnology
TX
2015
AEGLEA BIOTHERAPEUTICS, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT March 10, 2015 TABLE OF CONTENTS
Investor Rights Agreements
Aeglea BioTherapeutics, Inc.
2015
AEGLEA BIOTHERAPEUTICS, INC. 2015 EQUITY INCENTIVE PLAN As Adopted on March 10, 2015
Bonus & Incentive Agreements
Aeglea BioTherapeutics, Inc.
Biotechnology
TX
2015
AEGLEA BIOTHERAPEUTICS, INC. STOCK RESTRICTION AGREEMENT
Stock Agreements
Aeglea BioTherapeutics, Inc.
2015
SPONSORED RESEARCH AGREEMENT NO. UTA13-001113
Aeglea BioTherapeutics, Inc.
2015
Master Services Agreement
Services Agreements
Aeglea BioTherapeutics, Inc.
Biotechnology
NC
2015
OFFICELEASE BETWEEN BARTON OAKS OFFICE CENTER, LLC (LANDLORD) AND AEGLEA DEVELOPMENTCOMPANY, INC. (TENANT) TABLE OF CONTENTS
Aeglea BioTherapeutics, Inc.
Biotechnology
TX
2015
CONSULTING AGREEMENT
Consulting Agreements
Aeglea BioTherapeutics, Inc.
2015
PATENT LICENSE AGREEMENT AGREEMENT NO. PM1401601
License Agreements
Aeglea BioTherapeutics, Inc.
2015
aegleabio.com Aeglea Biotherapeutics 901 MoPac Expressway South, Suite 250, Austin, TX 78746 ###-###-####
Aeglea BioTherapeutics, Inc.
2015